A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Steven W. Baertschi, PhD
Advertisement
Steven W. Baertschi, PhD is a senior research scientist at Eli Lilly and Company.
Articles by Steven W. Baertschi, PhD
A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.
Twenty pharmaceutical companies responded to this survey that addressed a range of stress testing issues such as study design, procedures, and types of conditions.
Advertisement
Latest Updated Articles
- AAPS Workshop Summary
Published: November 2nd 2012 | Updated:
- Pharmaceutical Stability: Scientific and Regulatory Considerations for Global Drug Development and Commercialization
Published: November 3rd 2012 | Updated:
- A Stress Testing Benchmarking Study
Published: February 21st 2003 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Comparator Selection & Supply: Best Practices for Clinical Success
5
